| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 23,720 | 23,880 | 08.06. | |
| 23,680 | 23,840 | 08.06. |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 37,500 | 25 | |||
| 30,000 | 25 | |||
| 24,180 | 240 | |||
| 23,900 | 240 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/bv3.htm [/URL] | ||||
| 240 | 23,720 | |||
| 240 | 23,400 | |||
| 1.002 | 0,000 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 1.482 | 0,358 | 530 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 09:04:51 | 24,060 | 50 |
| Tagesumsatz Xetra | -0,420 -1,73 % | 50 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Bavarian Nordic A/S: Bavarian Nordic - Transactions in Connection with Share Buy-Back Program | 12 | GlobeNewswire (USA) | ||
| 02.06. | Bavarian Nordic A/S: Bavarian Nordic Launches Next Tranche of Share Buy-Back Program | 10 | GlobeNewswire (USA) | ||
| 13.05. | Bavarian Nordic A/S: Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such | 25 | GlobeNewswire (USA) | ||
| 13.05. | Bavarian Nordic A/S Reveals Decline In Q1 Income | 25 | RTTNews | ||
| BAVARIAN NORDIC Aktie jetzt für 0€ handeln | |||||
| 13.05. | Bavarian Nordic A/S: Bavarian Nordic Announces Interim Results for the First Three Months of 2026 | 471 | GlobeNewswire (Europe) | COPENHAGEN, Denmark, May 13, 2026 - Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first three months of 2026.
Revenue for the first... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Mo | BioNTech startet Aktienrückkauf über bis zu 1 Milliarde Dollar | 4investors | BioNTech hat ein Aktienrückkaufprogramm für American Depositary Shares im Volumen von bis zu 1,0 Milliarde US-Dollar gestartet. Der Rückkauf läuft ab dem 8. Juni 2026 über die US-Technologiebörse Nasdaq... ► Artikel lesen | |
| Mo | Sangamo Therapeutics, Inc.: Sangamo Therapeutics Announces Exploration of Strategic Alternatives to Maximize Value for Stakeholders | GlobeNewswire (Europe) | RICHMOND, Calif., June 08, 2026 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (OTCQB Venture Market: SGMO), a genomic medicine company, today announced that, after extensive consideration of the... ► Artikel lesen | |
| 01:02 | Moderna, Inc.: Moderna and the University of Oxford Receive UK Authorization to Begin Phase 1/2 Study of Investigational mRNA Cancer Vaccine for People with Lynch Syndrome | ACCESS Newswire | Lynch syndrome is an inherited condition affecting 1 in 300 people that causes lifetime cancer risk of up to 80%[1]The INTERCEPT-Lynch trial is part of a scientific collaboration between the University... ► Artikel lesen | |
| Mo | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 08.06.2026 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 08.06.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 08.06.2026ISIN NameCA2328211081 CYTOPHAGE... ► Artikel lesen | |
| Mo | DBV Technologies S.A.: DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026 | GlobeNewswire (Europe) | Châtillon, France, June 8, 2026
DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026
In the Phase 3 VITESSE... ► Artikel lesen |